When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Weight loss goals may be at the forefront of many New Year's resolutions, which could push the exuberance for Eli Lilly LLY ...

These companies have track records of success, increasing dividends, and fantastic growth prospects, making them all ideal ...

Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses ...

It has been a great run, but US stocks are now “priced for perfection” and “increasingly vulnerable to a correction”, ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

In my last column about the Novo Nordisk Foundation, I wrote about the company’s efforts in anti-microbial resistance, an example of an area where impact investment was necessary to combat ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

At the time of writing GBP/CAD traded at around CA$1.7879, down roughly 0.2% from Wednesday’s opening rate. The Pound (GBP) struggled to garner investor interest on Wednesday and edged lower ...

President-elect Donald Trump criticized the US Supreme Court's decision to allow the sentencing hearing in his New York hush money case, terming it politically motivated. He remains confident in ...